Improving treatment services for substance abusers with comorbid depression

American Journal on Addictions

Volumn 13, Issue 3, 2004, Pages 295-304

  Womack, Sharon ^a   Compton, Wilson M ^a,c   Dennis, Michael ^b   McCormick, Scott ^b   Fraser, James ^b   Horton, Joseph C ^a   Spitznagel, Edward L ^a   Cottler, Linda B ^a  

^a WASHINGTON UNIVERSITY   (United States)

^b CHESTNUT HEALTH SYSTEMS   (United States)

^c NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG DEPENDENCE; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MENTAL HEALTH SERVICE; PATIENT CARE; PATIENT REFERRAL; PSYCHOTHERAPY; SUBSTANCE ABUSE; TREATMENT OUTCOME;

ADULT; CASE MANAGEMENT; DEPRESSION; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; INTERVENTION STUDIES; MALE; MIDDLE AGED; REFERRAL AND CONSULTATION; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 3042785082     PISSN: 10550496     EISSN: None     Source Type: Journal    
DOI: 10.1080/10550490490460102     Document Type: Article

References (51)

1. Charney DA, Paraherakis AM, Negrete JC, Gill KJ. The impact of depression on the outcome of addictions treatment. J Subst Abuse Treat. 1998;15:123-130.
2. Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug Alcohol Depend. 1997;48:135-141.
3. Regier D, Burke JD, Burke KV. Comorbidity of affective and anxiety disorders on the NIMH Epidemiologic Catchment Area Program. In: Maser JD, Cloninger CR, eds. Comorbidity of Mood and Anxiety Disorders. Washington, DC: American Psychiatric Press; 1990:113-122.
4. Kessler RC, McGonagle KA, Zaho S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;5:8-19.
5. Kessler RC, Crum RM, Warner LA, Nelson CB, Schulenberg J, Anthony JC. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry. 1997;54:313-321.
6. Weissman MM, Bruce ML, Leaf PJ, Florio LP, Holzer III C. Affective disorders. In: Robins LN, Regier DA, eds. Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York: The Free Press; 1991:53-80.
7. Miller NS, Hoffmann NG, Ninonuevo F, Astrachan BM. Lifetime diagnosis of major depression as a multivariate predictor of treatment outcome for inpatients with substance use disorders from abstinence-based programs. Ann Clin Psychiatry. 1997;9:127-137.
8. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991;48:43-51.
9. Grant BF. The influence of comorbid major depression and substance use disorders on alcohol and drug treatment: results of a national survey. In: Onken L, Blaine JC, Genser S, Horton Jr AM, eds. Treatment of Drug Dependent Individuals with Comorbid Mental Disorders. NIDA Research Monograph 172. NIH Publication No. 97-4172. Washington, DC: NIH; 1997.
10. Allen MH, Frances RJ. Varieties of psychopathology found in patients with addictive disorders: a review. In: Meyer RE, ed. Psychopathology and Addictive Disorders. New York: Guilford Press; 1986:17-38.
11. Compton WM, Cottler LB, Phelps DL, Ben Abdallah A, Spitznagel EL. Psychiatric disorders among drug dependent subjects: are they primary or secondary? Am J Addict. 2000;9:126-134.
12. Curran GC, Booth BM. Longitudinal changes in predictor profiles of abstinence from alcohol use among male veterans. Alcohol Clin Exp Res. 1999;23:141-143.
13. Schuckit MA. Genetic and clinical implications of alcoholism and affective disorder. Am J Psychiatry. 1986;143:140-147.
14. Weissman MM, Myers JK, Harding PS. Prevalence and psychiatric heterogeneity of alcoholism in a United States urban community. J Stud Alcohol. 1980;4:672-676.
15. McMahon RC, Malow R, Loewinger L. Substance abuse history predicts depression and relapse status among cocaine abusers. Am J Addict. 1999;8:1-8.
16. Dixon L, McNary S, Lehman A. One-year follow-up of secondary versus primary mental disorder in persons with comorbid substance use disorders. Am J Psychiatry. 1997;154:1610-1612.
17. Curran GM, Flynn HA, Kirchner J, Booth BM. Depression after alcohol treatment as a risk factor for relapse among male veterans. J Subst Abuse Treat. 2000;19:259-265.
18. Perez-Stale E, Miranda J, Munoz RF, Ying Y-W. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Intern Med. 1990;150:1083-1088.
19. Etheridge RM, Craddock SG, Dunteman GH, Hubbard RL. Treatment services in two national studies of community-based drug abuse treatment programs. J Subst Abuse. 1999;7:9-26.
20. Etheridge RM, Hubbard RL, Anderson J, Craddock SG, Flynn PM. Treatment structure and program services in the Drug Abuse Treatment Outcome Study (DATOS). Psychol Addict Behav. 1997;11:244-260.
21. Gerstein D, Datta AR, Ingels J, et al. Final Report National Treatment Improvement Evaluation Survey. Contract No. ADM 270-92-0002. Rockville, Md.: Center for Substance Abuse Treatment, Substance Abuse and Mental Health Services Administration; 1997.
22. Batki SL, Wheeler S, Jones R, Sorensen J, Brennan K. Doxepin treatment of depressed opiate addicts undergoing methadone detoxification. In: Harris LS, ed. Problems of Drug Dependence, 1987, NIDA Research Monograph 81. DHHS Publication No. (ADM) 88-1564. Washington, DC: Alcohol, Drug Abuse, and Mental Health Administration; 1988.
23. Dorus W, Ostrow DG, Anton R, Cushman P, et al. Lithium treatment of depressed and non-depressed alcoholics. JAMA. 1989;262:1646-1652.
24. Mason BJ, Kocsis JH, Ritvo EC, Cutler RB. A double-blind, placebo-controlled trial of desipramine for primary alcohol dependence stratified on the presence or absence of major depression. JAMA. 1996;275:761-767.
25. Nunes EV, McGrath PJ, Quitken FM, et al. Imipramine treatment of alcoholism with comorbid depression. Am J Psychiatry. 1993;150:963-965.
26. Nunes EV, Quitken F, Brady R, Post-Koenig T. Antidepressant treatment in methadone maintenance patients. J Addict Dis. 1994;13:13-24.
27. Woody GE, O'Brien CP, McLellan AT, Apple T, Marcovici M, Evans BD. The use of antidepressants with methadone in depressed maintenance patients. Ann NY Acad Sci. 1982;398:120-127.
28. Bachrach LL. The challenge of service planning for chronic mental patients. Community Ment Health J. 1986;22:170-174.
29. Bachrach LL. The context of care for the chronic mental patient with substance abuse problems. Psychiatr Q. 1987;58:3-14.
30. Gustafson JS, Reda JL, McMullen H, et al. State Resources and Services Related to Alcohol and Other Drug Problems, Fiscal Year 1994. An Analysis of State Alcohol and Drug Abuse Profile Data. Washington, D.C.: National Association of State Alcohol and Drug Abuse Directors, Inc.; 1996.
31. Hser Y, Grella CE, Hsieh S, Anglin MD, Brown BS. Prior treatment experience related to process and outcomes in DATOS. Drug Alcohol Depend. 1999;57:137-150.
32. Woody GE, McLellan AT, Luborsky L, O'Brien CP. Psychotherapy and counseling for methadone-maintained opiate addicts: results of research studies. In: Onken LS, Blaine JD, eds. Psychotherapy and Counseling in the Treatment of Drug Abuse. NIDA Research Monograph 104. Rockville, U.S. Department of Health and Human Services; 1990:9-12.
33. Fiorentine R, Anglin MD. Does increasing the opportunity for counseling increase the effectiveness of outpatient drug treatment? Am J Drug Alcohol Abuse. 1997;23:369-382.
34. McLellan AT, Hagan TA, Levine M, et al. Does clinical case management improve outpatient addiction treatment? Drug Alcohol Depend. 1999;55:91-103.
35. Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: getting started and moving on from stage I. Clinical Psychology: Science and Practice. 2001;8:133-142.
36. Wells K, Burnam MA, Rogers W, Hays R, Camp P. The course of depression in adult outpatients: results from the medical outcomes study. Arch Gen Psychiatry. 1992;19:788-794.
37. Rost K, Nutting PA, Smith J, Werner JJ. Designing and implementing a primary care intervention trial to improve the quality and outcomes of care for major depression. Gen Hosp Psychiatry. 2000;22:66-77.
38. Dennis ML. Global Appraisal of Individual Needs (GAIN): Administration Guide for the GAIN and Related Measures. Bloomington, IL: Chestnut Health Systems; 1999. Available at: http://www.chestnut.org/LI/gain/GAIN_I/Gi1299.pdf. Accessed April 28, 2004.
39. Derogatis LR, Lipman RS, Rickels J, Uhlenhuth EH, Covi L. The Hopkins Symptom Checklist: a self-report symptom inventory. Behav Sci. 1974;19:1-15.
40. Zimmerman M, Coryell W, Corenthal C, Wilson S. A self-report scale to diagnose major depressive disorder. Arch Gen Psychiatry. 1986;43:1076-1081.
41. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994.
42. Depression Guideline Panel. Depression in Primary Care: 1. Detection and Diagnosis. Clinical Practice Guideline Number 5. AHCPR Publication No. 93-0550. Rockville, Md. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
43. Depression Guideline Panel. Depression in Primary Care: 2. Treatment of Major Depression. Clinical Practice Guideline Number 5. AHCPR Publication No. 93-0551. Rockville, Md. U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
44. Mee-Lee D. American Society of Addiction Medicine (ASAM): Patient Placement Criteria for the Treatment of Substance-Related Disorders. 2nd ed. (ASAM PPC-2). Chevy Chase, MD: The American Society of Addiction Medicine; 1996.
45. Depression Guideline Panel. Depression in Primary Care: 1. Depression is a Treatable Illness-a Patient's Guide. AHCPR Publication No. 93-0553. Rockville, Md.: U.S. Department of Health and Human Services, Public Health Service, Agency for Health Care Policy and Research; 1993.
46. Rollnick S, Miller WR. What is motivational interviewing? Behavioural and Cognitive Psychotherapy. 1995;23:325-334.
47. The SAS System. Windows, Version 8. Cary, North Carolina: SAS Institute, Inc.; 1999.
48. Dennis ML, Lennox RD, Foss MA. Practical power analysis for substance abuse health services research. In: Bryant KJ, Windle M, West SG, eds. The Science of Prevention: Methodological Advances from Alcohol and Substance Abuse Research. Washington, DC: American Psychological Association; 1997:367-405.
49. Cohen J. Statistical Power Analysis for Behavioral Sciences. 2nd ed. New York: Academic Press; 1988.
50. Allen K. Development of an instrument to identify barriers to treatment for addicted women, from their perspective. Int J Addict. 1994;29:429-444.
51. Katon W, Von Korff M, Lin E, et al. Collaborative management to achieve treatment guidelines: impact on depression in primary care. JAMA. 1995;273:1026-1031.